AusBiotech Investment

AusBiotech Investment is the national platform for investor readiness, capital engagement and capital formation across Australia’s life sciences sector.

As Australia’s leading life sciences industry body, AusBiotech is uniquely positioned to connect science, capability and capital through year-round programs, curated engagement and market-facing activity.

Built on more than 40 years of sector leadership, AusBiotech Investment is designed to strengthen the conditions for long-term investment by improving company readiness, increasing the visibility of high-quality opportunities, and supporting more effective capital conversations.

Where science, capability and capital connect

Australia produces world-class life sciences research, but scientific excellence alone does not create investable companies.

Capital formation depends on a broader set of conditions: commercial discipline, investor readiness, strategic visibility and access to the right capital at the right stage.

AusBiotech Investment exists to strengthen these conditions. Through an always-on model, it supports both companies and investors with more structured pathways to engagement, helping build a stronger pipeline of investment opportunities across the Australian life sciences ecosystem.

Our focus
• Investor readiness
• Company visibility
• Investor engagement
• Capital formation

AusBiotech Investment Programs

The Investment Readiness Panel (IRP)

The IRP supports Australian life sciences companies to better prepare for investor engagement and future capital raising.

Through structured, stage-relative feedback and investor-informed assessment, the IRP helps companies strengthen their investment proposition, sharpen their commercial and capital narrative, and better understand what sophisticated investors look for at each stage of growth.

Apply here →

AusBiotech Invest

AusBiotech’s flagship investment platform and event series, designed to bring companies, investors and sector leaders together for high-value capital conversations.

Moving beyond standard pitch formats to create more commercially relevant engagement through curated discussions, investor perspectives, market insights and company showcases. For investors,
it provides access to emerging opportunities, sector intelligence and companies preparing for their next phase of growth. For companies, it creates a more informed and strategic pathway to investor engagement.

Our always-on approach

AusBiotech Investment is designed to support capital formation across the company lifecycle, not only at discrete event moments.

Its year-round activity includes investor readiness support, capital conversations, targeted introductions, investor briefings, one-to-one partnering and flagship engagement points such as AusBiotech Invest.
This integrated model helps improve both company preparedness and the broader investment profile of Australian life sciences, creating stronger foundations for sustained investor engagement over time.